Health & Fitness
Health and Fitness
Health and Fitness
Wed, April 3, 2013Tue, April 2, 2013Mon, April 1, 2013Fri, March 29, 2013Thu, March 28, 2013Wed, March 27, 2013Tue, March 26, 2013Mon, March 25, 2013Sun, March 24, 2013Fri, March 22, 2013Thu, March 21, 2013Wed, March 20, 2013Tue, March 19, 2013Mon, March 18, 2013Sun, March 17, 2013Fri, March 15, 2013Thu, March 14, 2013Wed, March 13, 2013Tue, March 12, 2013Mon, March 11, 2013Sun, March 10, 2013Sat, March 9, 2013Fri, March 8, 2013Thu, March 7, 2013Wed, March 6, 2013ProMetic to Report its Fourth Quarter and Year End 2012 Financial Results and Hold Conference Call/Webcast
Published in Health and Fitness on Tuesday, March 19th 2013 at 9:16 GMT by Market Wire
March 19, 2013 12:03 ET
ProMetic to Report its Fourth Quarter and Year End 2012 Financial Results and Hold Conference Call/Webcast
LAVAL, QUEBEC--(Marketwire - March 19, 2013) -ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic" or the "Corporation") today announced that it will report its financial results for the fourth quarter and fiscal year ended December 31, 2012 on Tuesday, March 26, 201 3 after market trading hours.
ProMetic will host a conference call at 11:00am (EDT) on Wednesday, March 27, 2013. The telephone numbers to access the conference call are (416) 981-9000 (International) and 1-800-755-1805 (North America Toll-Free). A live audio webcast of the conference call will be available via [ http://www.gowebcasting.com/4228 ]
An audio replay of the call will be available for a period of seven days as of Wednesday March 27, 2013, at 1:30pm (EDT). The numbers to access the audio replay are (416) 626-4100 (international) and 1 (800) 558-5253 (North America Toll Free) using access code: 21652529.
About ProMetic Life Sciences Inc.
ProMetic Life Sciences Inc. ("ProMetic") ([ www.prometic.com ]) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Laval (Canada), ProMetic has R&D facilities in the U.K., the U.S. and Canada, manufacturing facilities in the U.K. and business development activities in the US, Europe, Asia.
